GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NKGen Biotech Inc (NAS:NKGN) » Definitions » Other Current Payables

NKGen Biotech (NKGen Biotech) Other Current Payables : $0.11 Mil (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is NKGen Biotech Other Current Payables?

NKGen Biotech's Other Current Payables for the quarter that ended in Mar. 2024 was $0.11 Mil.

NKGen Biotech's quarterly Other Current Payables increased from Sep. 2023 ($0.22 Mil) to Dec. 2023 ($0.29 Mil) but then declined from Dec. 2023 ($0.29 Mil) to Mar. 2024 ($0.11 Mil).

NKGen Biotech's annual Other Current Payables declined from Dec. 2021 ($1.87 Mil) to Dec. 2022 ($0.03 Mil) but then increased from Dec. 2022 ($0.03 Mil) to Dec. 2023 ($0.29 Mil).

NKGen Biotech Other Current Payables Historical Data

The historical data trend for NKGen Biotech's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NKGen Biotech Other Current Payables Chart

NKGen Biotech Annual Data
Trend Dec21 Dec22 Dec23
Other Current Payables
1.87 0.03 0.29

NKGen Biotech Quarterly Data
Dec21 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24
Other Current Payables Get a 7-Day Free Trial 0.03 - 0.22 0.29 0.11

NKGen Biotech Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

NKGen Biotech Other Current Payables Related Terms

Thank you for viewing the detailed overview of NKGen Biotech's Other Current Payables provided by GuruFocus.com. Please click on the following links to see related term pages.

NKGen Biotech (NKGen Biotech) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NKGen Biotech Inc (NAS:NKGN) » Definitions » Other Current Payables
Comparable Companies
OCUP CASI SPRO XLO NGM GBIO ASMB CCCC OCEA FIXX OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
N/A
Address
19700 Fairchild Road, Suite No. 300, Irvine, CA, USA, 92612
Website
https://www.nkgenbiotech.com
NKGen Biotech Inc is a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous, allogeneic and CAR-NK natural killer cell therapies utilizing our proprietary SNK (super-activated) platform.